Article Details
Retrieved on: 2021-07-26 13:07:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
This is an investigational next-generation CD20 monoclonal antibody, and this was in a relapsed/refractory patient population with high-risk features, ...
Article found on: www.pharmacytimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here